Patents by Inventor Lawrence Kauvar

Lawrence Kauvar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080038755
    Abstract: A multiplicity of applications of the CellSpot™ assay method are described. Among these applications are extension to integral membrane protein probes, extension to secretion from bacterial cells, identification of antibodies with enhanced affinity, identification of clones with increased secretion levels, and use of massively parallel screening to identify rare efficacious antibodies.
    Type: Application
    Filed: July 12, 2007
    Publication date: February 14, 2008
    Inventors: Lawrence KAUVAR, William Harriman, Ellen Collarini, April Dutta
  • Publication number: 20050266500
    Abstract: Intermolecular binding can be detected by formation of a “paratope” which results in an immediate generation of a signal. The substances to be tested for interaction are bound to demitopes, wherein said demitopes are components of a paratope which binds a reporter which provides said signal when bound. Known interactions measured in this way can also be employed to screen for compounds which interfere with the interactions. In addition to testing for individual interactions, the interaction of a compound with a library or library×library interactions can also be determined and the effect of potentially interfering substances evaluated.
    Type: Application
    Filed: July 21, 2005
    Publication date: December 1, 2005
    Applicant: Trellis Bioscience, Inc.
    Inventor: Lawrence Kauvar
  • Publication number: 20050136454
    Abstract: Assays for detecting the presence and activity of cell-signaling components. These assays include luminescence polarization assays for detecting cell-signaling nucleotides and modulators of receptors and enzymes related to the generation and activity of such nucleotides.
    Type: Application
    Filed: October 18, 2004
    Publication date: June 23, 2005
    Inventors: J. Sportsman, Lawrence Kauvar
  • Publication number: 20050124008
    Abstract: Homogeneous assays wherein an unlabeled analyte is detected by displacing a more weakly binding tracer from a binding partner are described. The tracer has signal generating properties which differ when bound or unbound to the binding partner.
    Type: Application
    Filed: December 3, 2004
    Publication date: June 9, 2005
    Inventor: Lawrence Kauvar
  • Publication number: 20050106641
    Abstract: New applications for the use of distinguishable particulate labels available in a variety of hues and sized in the submicron range are described. These applications include profiling of cellular components, obtaining secretion patterns, identifying a multiplicity of components in chromatographic or electrophoretic techniques and identification of desired immunoglobulin secreting cells.
    Type: Application
    Filed: November 3, 2004
    Publication date: May 19, 2005
    Inventors: Lawrence Kauvar, Remy Cromer, William Harriman
  • Publication number: 20050037409
    Abstract: Methods to identify proteins useful as translocation markers employ fusions of these proteins with common epitopes. An improved method for shotgun cloning employs pre-identified particulate labeled members of nucleic acid libraries. Methods to identify proteins useful as translocation markers employ fusions of these pre-identified particulate labeled members of nucleic acid libraries. An improved method for reporter gene assays employs parallel detection of multiple reporters using distinguishable particulate or antigenic labels coupled to specific detection agents for each reporter.
    Type: Application
    Filed: July 29, 2004
    Publication date: February 17, 2005
    Inventor: Lawrence Kauvar
  • Patent number: 6054286
    Abstract: Compounds having immunomodulating activity are identified using a methodology which employs TER14687, TER10311 and/or TER17210 as standards. The effect candidate compounds have on PKC-theta interaction with cognate binding proteins is measured and compared with the standards. The interaction can be measured by a variety of techniques, including assessing translocation of said PKC-theta or fragment. Kits containing the TER14687, TER10311 and/or TER17210 standards are disclosed. TER14687, TER10311 and/or TER17210 are useful in modulating the immune system in a subject by reducing T-cell activity. TER14687, TER10311, TER17210 are used as leads to develop other compounds having immunomodulating activity.
    Type: Grant
    Filed: January 15, 1999
    Date of Patent: April 25, 2000
    Assignee: Telik, Inc.
    Inventors: Hugo O. Villar, John Patterson, Anna Voronova, Dorit Ron, Lawrence Kauvar, Gene Napolitano, Nicki Vasquez